OGN News and Press, Organon & Co. From 09/30/21

It's time to look at the September 2021 period and look at how the portfolio performed. We saw an exciting dip, and as a result, significant buying opportunities. I took advantage and put almost $13,000 to work. Thanks to a truly massive extraordinary dividend from Swedish Handels...

Organon is a new company listed on June after the spin-off from Merck. Spin-off companies tend to outperform the broad market. In addition, the company has initiated its first dividend so dividend growth and income investors will enjoy it too. For further details see: Or...

Organon wants to help women take control of their birth control Canada NewsWire Building on vision to create a better and healthier every day for every woman, Organon wants to empower women so they can be in full control of their sexual health KIRKLAND, QC , ...

Dislocations between price and value remind me that it's a market for stocks rather than the stock market. I highlight 2 names that are trading in deep value territory and are set up for potentially strong gains. Both pay a well-covered dividend with plenty of room for growth. ...

Building on its vision to create a better and healthier every day for every woman, Organon launches Public Service Announcement video to challenge and help reduce stigma of global public health issue Organon (NYSE: OGN), a global women’s health company, is launching a...

Prem Watsa’s 13F portfolio value increased from $2.87B to $3.11B this quarter. Fairfax Financial's largest three stakes are Atlas Corp, BlackBerry, and Resolute Forest Products. They together account for ~76% of the 13F assets. The 13F securities form a small portion of the...

This Buffett holdings list from Kiplinger first appeared 8/17/21 online. YCharts and Dogs of The Dow also track this Buffett/Berkshire Batch. Here is your update from 9/16/21 YCharts data. 29 of 44 current Berkshire Hathaway-owned-stocks pay dividends. As of 9/16/21, the top-ten range...

Organon has shown disappointing share price performance since being spun-off from Merck. However, its business fundamentals are solid, with Women's Health and Biosimilars segments showing promising growth. I highlight why Organon is a solid value Buy at the moment for income and g...

Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at Morgan Stanley’s 19th Annual Global Healthcare Virtual Conference on Monday, September 13, 2021 at 9:30 a.m...

Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at Citi’s 16th Annual BioPharma Virtual Conference on Friday, September 10, 2021 at 9:45 a.m. EDT. Investo...